"Survived Two Lethal Injections": U.S. Death Row Inmate Wakes Up One Week After Failed Execution

Legal Team: “Medically Unprecedented Recovery”
Tennessee Suspends All Executions for the Year

A female death row inmate in the United States who survived two separate administrations of an execution drug regained consciousness about a week after the attempt. This unprecedented execution failure has reignited controversy over the efficacy of drugs used in lethal injections, the process by which they are procured, and the level of pain inflicted on death row inmates in the U.S.

On October 7, according to Yonhap News citing foreign press such as the Associated Press, Krista Pike (age 50), who was subjected to lethal injection at a prison in Nashville, Tennessee on September 30, regained consciousness and is now able to speak.

Krista Pike, a US death row inmate who survived execution by poison. Photo by Reuters Yonhap News

Pike’s legal team issued a statement saying that she is currently conscious and able to communicate. However, she continues to receive intensive care and has sustained serious injuries to both arms. The lawyers claimed that despite these injuries, Pike remains handcuffed and shackled to her hospital bed. They described her recovery as “medically unprecedented,” adding that “the prognosis remains uncertain and at minimum a lengthy recovery is expected.” Tennessee correctional authorities acknowledged that Pike is currently hospitalized but have not released additional details about her medical condition.

Two Doses of Execution Drug Failed to Cause Death

During the execution procedure on September 30, Pike was administered pentobarbital, a drug commonly used as a sedative or anesthetic. However, she did not die after the first dose, and even after a second administration, she continued to breathe, prompting officials to halt the execution. Pike was then rushed to a hospital, where she remained unconscious for some time before beginning treatment.

Pike was convicted and sentenced to death for murdering 19-year-old Colleen Slemmer, along with her boyfriend and others, in 1995 when she was 18. She has been imprisoned for nearly 30 years since. Experts note that this incident differs even from other failed executions.

Although there have been past cases in the U.S. where lethal injections were suspended due to problems securing a vein or malfunctioning equipment, in Pike’s case, she survived despite receiving two doses of execution drugs. After the incident, Tennessee Governor Bill Lee ordered a comprehensive third-party review of the state’s entire execution process. He also announced a suspension of all additional executions slated for this year. Frank Strada, the Commissioner of the Tennessee Department of Correction, who oversaw executions, expressed his intention to resign.

Pharmaceutical Companies Halt Supply of Execution Drugs, Disrupting Supply Networks

This incident has also brought the procurement process of drugs used in lethal injections in the United States back into the spotlight. According to the Wall Street Journal on October 3, major American pharmaceutical companies have imposed supply restrictions to prevent their products from being used in executions. Because it has become difficult to obtain execution drugs through legitimate distribution channels, some state governments are reported to have resorted to compounding pharmacies or untraceable supply networks to obtain them.

The recent incident has put the procurement methods of drugs used for lethal injection in the United States back under scrutiny. According to the Wall Street Journal (WSJ) on the 3rd, major pharmaceutical companies in the U.S. have been implementing supply restrictions to prevent their medicines from being used in executions. The photo is not related to the specific content of the article. Pixabay

The controversy surrounding pentobarbital itself—the drug administered to Pike—is also growing. Pentobarbital is a barbiturate that suppresses the central nervous system. Several U.S. states use it as a single-agent drug in lethal injections, and it has also been adopted by the federal government for executions.

The first Trump administration resumed federal executions in 2019 and introduced the single-drug pentobarbital method. However, the Biden administration suspended federal executions in 2021 and, as of January 2025, abolished the existing federal execution procedures using pentobarbital. At the time, the Department of Justice cited significant uncertainty whether the drug could cause unnecessary pain and suffering to inmates. The second Trump administration reversed this decision in April and reinstated the pentobarbital lethal injection process.

Particularly, studies have pointed out that use of pentobarbital may cause pulmonary edema (fluid accumulation in the lungs), raising the possibility that inmates might experience sensations similar to suffocation or drowning. On the other hand, some argue that because the drug induces loss of consciousness quickly, it is unclear how much pain the inmate actually perceives. Death row inmates in Tennessee have also filed lawsuits against the state, claiming that the current lethal injection method risks causing extreme suffering.

As Lethal Injection Faces Scrutiny, Firing Squads and Nitrogen Gas Reemerge

As the debate over lethal injection continues, some states in the U.S. are reconsidering alternative execution methods. Idaho, Mississippi, Oklahoma, South Carolina, and Utah permit firing squads under certain conditions, while states such as Alabama have legalized execution using nitrogen gas. In April, the Trump administration also revised federal execution procedures to allow methods such as firing squads in addition to pentobarbital lethal injections.

Lethal injection was introduced in the U.S. in the late 1970s with the aim of providing a swifter and less painful alternative to the electric chair or hanging. Although it has since become the most common method of execution, ongoing issues regarding drug procurement, repeated failures, and controversy over the pain experienced by inmates continue to fuel debate. In particular, the Pike case is likely to further intensify controversy over the reliability of the U.S. death penalty system and its execution methods, as this was not just a matter of failing to secure a vein, but rather a case in which the inmate survived multiple administrations of execution drugs.

This content was produced with the assistance of AI translation services.